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Kosinostatin (KST), an antitumor antibiotic, features
a pyrrolopyrrole moiety spirally jointed to a five-
membered ring of an anthraquinone framework
glycosylated with a g-branched octose. By a combi-
nation of in silico analysis, genetic characterization,
biochemical assay, and precursor feeding experi-
ments, a biosynthetic pathway for KST was pro-
posed, which revealed (1) the pyrrolopyrrole moiety
originates from nicotinic acid and ribose, (2) the bicy-
clic amidine is constructed by a process similar to
the tryptophan biosynthetic pathway, and (3) a
discrete adenylation enzyme and a peptidyl carrier
protein (PCP) are responsible for producing a PCP-
tethered building block parallel to type II polyketide
synthase (PKS) rather than for the PKS priming step
by providing the starter unit. These findings provide
an opportunity to further explore the inexplicable
enzymatic logic that governs the formation of pyrro-
lopyrrole moiety and the spirocyclic skeleton.
INTRODUCTION
Aromatic polyketide natural products include many clinically
important drugs such as oxytetracycline (antibacterial) and
daunorubicin/doxorubicin (anticancer). Kosinostatin (KST, 1),
one of this family of natural products, was originally isolated
from Streptomyces aureofaciens in the 1950s (Tulinsky, 1964),
and was subsequently re-isolated frommarineMicromonospora
sp. TP-A0468 in Japan (Furumai et al., 2002; Igarashi et al., 2002)
and S. violaceusniger HAL64 in Egypt (El-Naggar, 2007) along
with its naturally occurring analog isoquinocycline B (2). KST
strongly inhibits the growth of Gram-positive bacteria with amin-
imum inhibitory concentration (MIC) value of 0.039 mg/ml, and
has a modest inhibition effect on Gram-negative bacteria and
yeasts. It also shows cytotoxicity against various cancer cell796 Chemistry & Biology 20, 796–805, June 20, 2013 ª2013 Elsevierlines with IC50 ranging from 0.02–0.6 mM and inhibits human
DNA topoisomerase IIa with IC50 of 3–10 mM (Furumai et al.,
2002). KST is structurally characterized by an unusual bicyclic
amidine (rings F and G) connecting C7 and C9O via anN,O-spiro
center to form a 2,4,5,6-tetrahydropyrrolo[2,3-b]pyrrole, a
molecular architecture that has not been found in any other
natural products (Figure 1). Another remarkable feature of KST
is the inclusion of an anthraquinoid tetracycle (rings ABCD) gly-
cosylated at C10 with a g-branched octose, which is not often
observed in secondary metabolites. The structure of KST was
elucidated by X-ray crystallography (Tulinsky, 1964) and nuclear
magnetic resonance (NMR) analysis (Igarashi et al., 2002; El-
Naggar, 2007). Although the chemical synthesis of the branched
octose (Ko¨nig et al., 2007) and pyrrolopyrrole substructure were
reported (Cordes et al., 2010; Breuning et al., 2011), the total
synthesis of KST has still not been accomplished.
Most bacterial aromatic polyketides are biosynthesized
from malonyl-CoA precursors by type II polyketide synthases
(PKSs). A three-enzyme cassette, also called ‘‘minimal PKS’’
consisting of a ketosynthase (KSa), a chain length factor (CLF
or KSb), and an acyl carrier protein (ACP), is necessary for the
elongation cycle of the polyketide chain in an iterative manner
(Hertweck et al., 2007; Das and Khosla, 2009). Additional
tailoring enzymes including ketoreductase (KR), aromatase,
and cyclase are required to promote the regioselective folding
and cyclization of the nascent polyketide chain to form the aro-
matic ring system (Zhou et al., 2010). A host of tailoring enzymes
perform further modifications such as oxidation, reduction,
methylation, and glycosylation to yield a large number of com-
pounds of great structural diversity (Hertweck et al., 2007; Das
and Khosla, 2009). The quinocycline structure of KST suggests
that the skeleton is most likely biosynthesized by a type II PKS.
However, three unusual structural features of KST are of special
interest. First, it is difficult to propose the precursor origins of the
unprecedented pyrrolopyrrole structure according to the known
biological formation of pyrroles (Walsh et al., 2006), which also
suggests that unique biosynthetic machinery should be involved
in themoiety formation. Second, the presence of the g-branched
octose suggests that additional sugar modification steps might
be necessary based on the current deoxysugar biosyntheticLtd All rights reserved
Figure 1. Proposed Biosynthetic Pathway of KST
(A) Localization of the cloned DNA region fromMicromonospora sp. TP-A0468 as represented by two overlapping fosmids and organization of KST gene cluster.
(B–E) Proposed model for type II PKS and PKS-associated modification (B), NRPS and formation of the bicyclic amidine (C), glycosylation relative modification
(D), and deoxysugar pathway (E). Color coding indicates the genes for the anthracycline (blue), aminopyrrole (red), bicycled amidine (green), deoxy sugar (purple),
and all other genes (black).
See also Tables S1–S3 and Figures S3, S4, and S9.
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includes an N,O-spiro center, which indicates that an alternate
hybrid system or complex rearrangement is possibly involved
to construct the framework.
To solve these biosynthetic puzzles, in this study we have (1)
cloned and analyzed the biosynthetic gene cluster of KST, (2)
characterized the functions of genes involved in this cluster by
gene inactivation, (3) isolated and structurally elucidated inter-
mediates from mutant strains, (4) traced the substrate origin by
feeding experiments with 13C-labeled precursors, and (5) bio-
chemically characterized the substrate of the adenylation (A)
enzyme and peptidyl carrier protein (PCP) of nonribosomal pep-
tide synthetase (NRPS). Based on these results, we propose aChemistry & Biology 20,biosynthetic pathway for KST that is distinct from the currently
known PKS paradigms, which sets the stage for further charac-
terization of unique biosynthetic machineries and production
of novel aromatic polyketide derivatives by combinatorial
biosynthesis.
RESULTS
Cloning and Validation of the Biosynthetic Gene Cluster
To identify the KST gene cluster, we adopted a PCR approach
using degenerate primers to access the genes encoding KSa
and CLF, which are conserved for type II PKSs that produce
angucycline-type polyketide (see Experimental Procedures).796–805, June 20, 2013 ª2013 Elsevier Ltd All rights reserved 797
Table 1. Deduced Functions of ORFs in KST Biosynthetic Gene Cluster
Gene
Amino
Acid Protein Homolog (Accession Number in GenBank), Origin
Similarity/
Identity (%) Proposed Function
orf(2)a 207 regulator (EEN37261), Cellulomonas flavigena DSM 20109 78/63 response regulator
orf(1)a 449 hypothetical (EEN37262), Cellulomonas flavigena DSM 20109 60/48 unknown
kstA4 268 Stf Y (CAJ42324), S. steffisburgensis 85/74 2,3-ring cyclase
kstB1 520 PltF (AAD24881), Pseudomonas fluorescens 48/34 NRPS (A)
kstB2 87 CloN5 (AAN65234), S. roseochromogenes. oscitans 57/28 NRPS (PCP)
kstC1 344 TrpD (EDY52420), S. clavuligerus ATCC 27064 58/48 anthranilate phospho-
ribosyltransferase
kstC2 273 TrpA (ABB41400), Thiomicrospira crunogena XCL-2 51/31 a-tryptophan synthase
kstB3 124 EctC(BAC47371), Bradyrhizobium japonicum USDA 110 64/48 L-ectoine synthase
kstB4 379 CaiA (EDY52417), S. clavuligerus ATCC 27064 78/65 acyl-CoA dehydrogenase
kstC3 231 PRAI (ABS13531), Ochrobactrum anthropi ATCC 49188 43/30 phosphoribosylanthranilate
isomerase
kstC4 232 IGPS (AAL81835), Pyrococcus furiosus DSM 3638 51/33 indoleglycerol phosphate synthase
kstRg1 294 LlpRIV (CAM34372), S. tendae 71/58 transcriptional activator
kstD1 298 NovV (AAF67515), S. caeruleus 83/70 dTDP-glucose synthase
KstD2 329 ChaS2 (CAH10168), S. chartreusis 79/66 dTDP-glucose 4,6-dehydratase
kstA5 259 AknU (AAF73457), S. galilaeus 74/60 ketoreductase
kstA6 319 Sim6 (AAL15584), S. antibioticus 70/59 aromatase
kstA7 261 AknA (BAB72043), S. galilaeus 83/75 C-9 ketoreductase
kstA8 152 AknX (AAF70105), S. galilaeus 69/62 monooxygenase
kstA1 422 StfP (CAJ42320), S. steffisburgensis 87/79 KSa
kstA2 402 Snoa2 (CAA12018), S. nogalater 79/69 CLF (KSb)
kstA3 85 NcnC (AAD20269), S. arenae 71/60 ACP
kstA9 144 ChaK (CAH10173), S. chartreusis 86/81 cyclase
kstA10 280 Orf25 (AAP85342), S. griseoruber 51/36 NAD(P)H:flavin oxidoreductase
kstA11 298 ActVA 4 (CAA41640), S. coelicolorA3 (2) 59/49 monooxygenase
kstRg2 262 Sim16 (AAL15594), S. antibioticus 50/38 transcriptional regulator
kstRs1 358 CosI (ABC00731), S. olindensis 77/64 ABC transporter
kstRs2 277 AviABC2 (AAG32069), S. viridochromogenes 50/38 ABC transporter
kstA12 363 Sce1919 (CAN92078), Sorangium cellulosum 56 50/38 carboxylesterase
kstRs3 491 Orf20 (ABL09967), S. echinatus 50/38 efflux protein
kstRs4 327 SnasDRAFT_41960 (EEP05837), Stackebrandtia nassauensis
DSM 44728
50/38 transporter
kstA13 150 MtmX (CAA61988), S. argillaceus 66/57 cyclase
kstD3 194 CmmF (CAE17549), S. griseus 64/52 3,5-epimerase
kstD4 336 AknT (AAF73456), S. galilaeus 49/43 glycosyl transferase associate
protein
kstD5 432 RdmH (AAL24450), S. purpurascens 72/57 glycosyl transferase
kstD6 498 SnogH (CAA12009), S. nogalater 72/61 2,3-hexose dehydratase
kstD7 341 ORF78 (BAC76536), S. rochei 76/64 pyruvate dehydrogenase-a
kstD8 345 ORF77 (BAC76535), S. rochei 83/72 pyruvate dehydrogenase-b
kstRs5 540 MCAG_04629 (EEP74302), Micromonospora ATCC39149 91/86 SNF2/RAD54 family helicase
kstRs6 433 MCAG_04630 (EEP74303), Micromonospora ATCC39149 91/84 hypothetical protein
kstU1 144 Sare_1463 (ABV97362), Salinispora arenicola CNS-205 88/81 unknown
kstRg3 401 XRE family regulator (EEP71048), Micromonospora ATCC 39149 60/46 regulator
kstU2 156 MCAG_00268 (EEP69941), Micromonospora ATCC 39149 84/78 unknown
kstU3 143 Sare_2967 (ABV98793), Salinispora arenicola CNS-205 60/43 unknown
kstRg4 75 GntR family regulator (ABW00126), Salinispora arenicola CNS-205 69/47 regulator
(Continued on next page)
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Table 1. Continued
Gene
Amino
Acid Protein Homolog (Accession Number in GenBank), Origin
Similarity/
Identity (%) Proposed Function
kstA14 172 Long-chain acyl-CoA dehydrogenase (AAH44447), Danio rerio 40/25 dehydrogenase
kstD9 327 PokS4 (ACN64828), S. diastatochromogenes 61/50 sugar 3-ketoreductase
kstC5 347 NADPH:quinone reductase (CAM05807), Saccharopolyspora erythraea
NRRL 233
66/55 enoyl reductase
kstA15 151 AclR (BAB72057), S. galilaeus 86/68 hydroxylase
kstA16 281 AclQ (BAB72056), S. galilaeus 67/59 hydroxylase
kstRg5 277 TetR family transcriptional regulator (EEP74304), M. sp. ATCC 39149 93/87 regulator
kstRs7 192 organic hydroperoxide resistance protein (CAL99539), Saccharopolyspora
erythraea NRRL 233
74/59 resistance protein
kstB5 361 D-alanyl-D-alanine carboxypeptidase (EDY67137), S. pristinaespiralis
ATCC 25486
71/58 dioxygenase
kstA17 499 AzicO1 (ADB02833), Kibdelosporangium sp. MJ126-NF4 65/52 FAD-dependent oxidoreductase
kstA18 286 AknG (AF257324), S. galilaeus 82/73 methyltransferase
kstB6 229 transglutaminase-like enzyme (ABP84680), Pseudomonas mendocina 65/44 aminotransferase
kstC6 507 carboxylyase-related protein (EFA32036), M. aurantiaca ATCC 27029 50/41 carboxylyase
kstB7 281 Streptogrisin B (EEP74305), M. sp. ATCC 39149 86/82 deformylase
orf(+1)a 320 transcriptional regulator (EEP74307), M. sp. ATCC 39149 85/79 regulator
orf(+2)a 286 PAS/PAC sensor kinase (ACV68221), Desulfohalobium retbaense
DSM 5692
45/24 regulator
orf(+3)a 186 NADPH-dependent FMN reductase (EFA29841), M. aurantiaca ATCC
27029
81/68 reductase
orf(+4)a 352 KitK (ABH05060), Kitasatospora putterlickiae 61/58 AHBA kinase
aorfs beyond KST gene cluster.
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Kosinostatin BiosynthesisBy screening of the Micromonospora sp. TP-A0468 genomic
library and the subsequent chromosome walking experiments,
an 82.5 kb contiguous DNA sequence was mapped into two
overlapping fosmids, pTG1701 and pTG1702 (Figure 1A).
Sequencing and bioinformatic analysis of these two fosmids re-
vealed 66 ORFs (Figure 1A), which are summarized in Table 1.
To confirm that the cloned gene cluster was essential for KST
biosynthesis, a mutant strain TG1701 was constructed in which
the kstA6 gene encoding aromatase was inactivated by gene
disruption (Figure S1 available online). The resulted mutant strain
completely lost its ability to produce KST and 2 (Figure 2A, III),
which was confirmed by high performance liquid chromatog-
raphy (HPLC), and liquid chromatography-mass spectrometry
(LC-MS) analysis established its correlation to KST biosynthesis.
Inactivation of the genes orf(2), orf(1), orf(+4), orf(+2), and
orf(+1) had no effect on KST production; whereas, inactivation
of kstB7 led to obviously decreased production of KST and 2
(Figures S1 and S3). Thus, the KST biosynthetic gene cluster
may range from kstA4 (encoding cyclase, which is usually
involved in type II PKS system) to kstB7, spanning 55.2 kb of
DNA and encompassing 55 ORFs (Figure 1A; Table 1).
PKS and PKS-Associated Enzymes
The minimal PKS in the KST pathway is encoded by kstA1 (KSa),
kstA2 (CLF), and kstA3 (ACP), which resemble their counterparts
in other type II PKS systems, particularly those involved in the
biosynthesis of anthracyclines (e.g., steffimycin) (Metsa¨-Ketela¨
et al., 2008; Gullo´n et al., 2006). KstA2 contains the characteristicChemistry & Biology 20,Q162 for typical CLF and is more closely related to CLF found in
the subgroup of PKSs that synthesize anthracycline polyketide
with a chain length of C-20 and an acetate starter unit (Figure S4).
Further analysis identified the gatekeeper residues of KstA2 as
G113-L117-W195-F110-G196-M151-F134, which show high
specificity toward the C-20 chain length using acetate as starter
unit (Table S3) (Tang et al., 2003; Keatinge-Clay et al., 2004).
After assembly by the minimal PKS, the nascent polyketide
chain is folded and regiospecifically cyclized to form an aromatic
ring; these steps are usually catalyzed by KR and aromatases/
cyclases (Zhou et al., 2010). In the gene cluster, two genes
(kstA5 and kstA7) encode proteins having high sequence homol-
ogy (60%–75% identity) with typical KRs and contain not only the
NAD(P)H-binding site but also the characteristic catalytic S–Y–K
triad (Metsa¨-Ketela¨ et al., 2008). Further phylogenetic analysis
and comparison with their homologs suggest that KstA7 is
more closely related to the KRs acting on the keto group at
C-9, whereas KstA5 is relatively close to the C-17 KRs (Lackner
et al., 2007). Candidate genes encoding aromatases or cyclases
in the cluster are kstA4, kstA6, kstA9, and kstA13. KstA6 is similar
to a class of aromatases that catalyze the dehydration/aromati-
zation of the anthracyclic polyketide A-ring (Metsa¨-Ketela¨ et al.,
2008), and is closer to the members responsible for the C7–C12
first-ring cyclization (Zhou et al., 2010; Fritzsche et al., 2008).
KstA4 shares high sequence similarity with StfY (74% identity),
which catalyzes the second and third cyclization steps in steffi-
mycin biosynthesis (Gullo´n et al., 2006). Two genes, kstA9 and
kstA13, encode two copies of cyclases that bear homology to796–805, June 20, 2013 ª2013 Elsevier Ltd All rights reserved 799
Figure 2. Characterization the Genes Involved in the Biosynthesis of
KST In Vivo
(A) HPLC analysis of KST production at 423 nm: (I) KST standard, (II) wild-type
Micromonospora sp. TP-A0468, (III) mutant TG1701 (DkstA6), (IV) TG1708
(DkstB1), (V) TG1709 (DkstC3), and (VI) TG1710 (DkstA12).
(B) Structure elucidation of 3 from TG1708 (DkstB1) or TG1709 (DkstC3) and 5
isolated from mutant TG1710 (DkstA12).
See also Tables S5 and S6 and Figures S1, S2, S7, S10, and S11.
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Kosinostatin BiosynthesisChaK (Xu et al., 2005) and StfX (Gullo´n et al., 2006), which were
both assigned as the fourth ring cyclases catalyzing an aldol-
type cyclization of the D-ring. The kstA18 gene encodes a800 Chemistry & Biology 20, 796–805, June 20, 2013 ª2013 ElsevierSAM-dependent methyl-transferase (MT), which shows high
sequence similarities with AknG (73% identity) and ChaI (61%
identity) from aklavinone (Chung et al., 2002) and chartreusin
(Xu et al., 2005) biosynthetic pathways, respectively. The kstA8
gene product is a monooxygenase and is similar to AknX (62%
identity), which is characterized as the anthrone oxygenase
involved in aklavinone biosynthesis (Chung et al., 2002). The
deduced protein of kstA15 is homologous to the aromatic
A-ring hydroxylase AclR (68% identity; Siitonen et al., 2012).
KstA11 shares the highest similarity with ActVA (49% identity;
Valton et al., 2008), whereas KstA10 is deduced to be a
NAD(P)H:flavin oxidoreductase. All of these post-PKS modifica-
tion enzymes were possibly responsible for the conversion of the
nascent polyketide chain into the final anthracycline building
block 3 (Figure 1B).
To verify the proposed pathway and to distinguish the cycli-
zation model of anthracycline, feeding experiments with the
KST-producing strain Micromonospora sp. TP-A0468 using
13C-labeled precursors were performed. Feeding [1-13C]-,
[2-13C]-, and [1,2-13C2]-acetate, respectively, revealed a labeling
pattern showing that the KST anthracycline skeleton is con-
structed in a standard manner after the assembly of ten acetate
units (Figures 3A and S5; Table S4). C-12a to C-1, and C-2 to C-3
were shown to derive from two intact acetate units, respectively,
indicating that the cyclization pattern of the polyketide chain
belongs to the mode of ‘‘S’’ folding (Thomas, 2001). Incorpora-
tion of the intact acetate units into C-7 to C-8, and C-9 to
C-13, respectively, together with the 13C enrichment at C-10
by feeding [2-13C]-acetate further supported the proposed
folding pattern and suggested a cryptic decarboxylation reaction
(Figure 1). The feeding experiments described herein not only
establish the folding mode of the anthracycline skeleton, but
also highlight a convergent biosynthetic strategy by connecting
two building blocks to form a spirocyclic skeleton.
Genetic and Biochemical Characterization of NRPS
Bioinformatic analysis allowed us to identify a pair of genes
(kstB1 and kstB2) encoding a discrete, monofunctional adenyla-
tion domain (A) enzyme and a PCP of NRPS. KstB1 resembles a
free-standing A domain and contains ten highly conserved
motifs (Figure S6). The substrate specificity-conferring codes
(Stachelhaus et al., 1999; Challis et al., 2000) for KstB1 are iden-
tified as D-235, L-236, L-239, Q-278, V-299, T-301, L-322,
D-330, S-331, and K-517, which have not been previously cate-
gorized. KstB2 displays sequence homology with both discrete
PCPs and ACPs containing the signature motif (VIDSLG) con-
taining the conserved serine residue for 40-phosphopantetheine
attachment.
To testify whether kstB1 contribute to the production of KST,
it was inactivated by gene replacement with the aac(3)IV apra-
mycin-resistance gene. The resultant DkstB1 mutant strain,
TG1708, completely abolished KST and 2 productions; instead,
produced a metabolite (Figure 2A, IV). This compound was iso-
lated and structural elucidated to be 3 (Figure 2B) by extensive
NMR analysis (Table S5; Figure S7). This result clearly confirmed
that kstB1 is essential for KST biosynthesis and further supports
the proposed biosynthetic pathway of anthracycline building
block 3 (Figure 1B). It also rules out the possibility that the
discrete A and PCP pair contributes to a potential nonacetateLtd All rights reserved
Figure 3. Biosynthetic Precursors of KST
Characterized by Feeding Experiments
(A) Summary of biosynthetic precursors of 2 with
13C-labeled sodium acetate and ribose.
(B) 13C-NMR spectra with (I) and without (II)
feeding of D-[2-13C]-ribofuranose. The enhanced
signal at d 22.3 (C-40) is marked.
See also Table S4 and Figure S5.
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2006; Zhang et al., 2008; Ogasawara and Liu, 2009).
To further characterize the function of KstB1 and KstB2, the
two genes were cloned and overexpressed in Escherichia coli
and the resulted proteins were purified to homogeneity (Fig-
ure S8). In vitro assays using HPLC to follow KstB1-dependent
aminoacylation of KstB2 (Figure 4A) unambiguously showed
that nicotinic acid could be effectively activated by KstB1 and
transferred onto holo-KstB2 to form a nicotinyl-S-PCP interme-
diate in an ATP-dependent activation manner (Figure 4B). The
105.0 Da shift in the Q-TOF-MS analysis is in agreement with
addition of a nicotinic acid moiety to the holo-PCP (Figure 4C).
These results suggested that nicotinic acid is a precursor to
afford the PCP-tethered intermediate 4 catalyzed by KstB1/
KstB2 (Figure 1C).
Post-NRPS Modification and Pyrrolopyrrole Formation
Several genes (i.e., kstB3–kstB7) are proposed to encode
enzymes associated with post-NRPS modifications to pro-Chemistry & Biology 20, 796–805, June 20, 2013duce a possible intermediate x (Figures
1C and S9A). KstB5 shows sequence
homology to members of b-lactamase
superfamily, such as D-alanyl-D-alanine
carboxypeptidase. Further sequence
examination revealed a ‘‘H–H–E/D’’
facial triad, which is consistent with the
iron (II) binding motif of dioxygenases
for extradiol ring-cleavage (Cho et al.,
2010). KstB7 belongs to a a/b-hydro-
lase-fold superfamily and contains the
conserved ‘‘S–D’’ catalytic triad, which
is essential for the enzyme activity of
deformylase (Jime´nez et al., 2008).
KstB6 is a transglutaminase-like amino-
transferase with conserved ‘‘C–H–D’’
catalytic triad. KstB3 is likely an ectoine
synthase-like enzyme (Reshetnikov
et al., 2006), whereas KstB4 resembles
an acyl-CoA dehydrogenase. The KST
cluster also contains several genes,
kstC1–kstC6, encoding a series of en-
zymes similar to the biosynthesis of
tryptophan or indole from anthranilate
(Figure S9B) (Jiroutova´ et al., 2007).
These enzymes are likely be involved in
the formation of pyrrolopyrrole building
block y from intermediate x using phos-
phoribose as substrate similar to trypto-
phan/indole biosynthesis (Figures 1Cand S9). To confirm these genes are involved in the biosyn-
thesis of KST, we inactivated kstC3 by gene replacement.
The DkstC3 mutant TG1709 no longer produced KST or 2 but
accumulated compound 3 confirmed by coinjection in HPLC
and LC-MS analysis (Figures 2A–2V). The identification of the
same intermediate produced by the mutant TG1708 (DkstB1)
and TG1709 (DkstC3) further supports the proposed biosyn-
thetic pathway (Figures 1B and 1C).
To further study the biosynthesis of the pyrrolopyrrole
moiety, we performed feeding experiments using D-[2-13C]-
ribofuranose, the proposed substrate used by tryptophan
biosynthesis. The specific and significant 13C enrichment
from D-[2-13C]-ribofuranose at C-40 in KST or 2 (Figure 3B)
strongly supported that C-50 to C-40 originated from
ribose, and corroborated our proposal (Figure 1C). Combin-
ing with biochemical identification of nicotinic acid as the
substrate of KstB1/B2, we have now fully established the
biosynthetic precursors of the scare pyrrolopyrrole moiety
of KST.ª2013 Elsevier Ltd All rights reserved 801
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Figure 4. In Vitro Aminoacylation of KstB2 by KstB1
(A) Enzymatic reaction.
(B) HPLC analysis (UV220 nm) of KstB1 (I), KstB2 (II), and aminoacylation of
KstB2 by KstB1 using nicotinic acid as substrate for 5 min (III).
(C) Q-TOF-MS analysis of holo-KstB2 (I) and nicotinyl-S-KstB2 (II). The m/z on
the x axis refer to themass to charge ratio, the charge of the protein is +15. (B)
holo-KstB2; (>) apo-KstB2; (7) KstB1; (C) nicotinyl-S-KstB2. All these PCP
species were confirmed by LC-MS analysis.
See also Figures S6 and S8.
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KST contains a rare g-branched octose characterized by a two-
carbon side chain at position C-4 of the deoxysugar. The gene
cluster contains nine genes, kstD1–kstD9, which encode en-
zymes possibly responsible for the biosynthesis of this unusual
sugar building block (10). Among them, a thymine diphosphate
(TDP)-glucose synthetase (KstD1), a TDP-glucose 4,6-dehydra-
tase (KstD2), a NDP-hexose 2,3-dehydratase (KstD6), a 3-ketor-
eductase (KstD9), and a 3,5-epimerase (KstD3) catalyze the
biosynthesis of NDP-4-keto-L-digitoxose (9) from glucose-1-
phosphate (Figure 1E). KstD7 shows sequence similarity with
the a-subunit of pyruvate dehydrogenase (PDH) E1 component
containing the highly conserved thiamine pyrophosphate (TPP)
binding motif GDG and E(X)4A(X)4P(X)3NNKY (Treede et al.,
2005), whereas the deduced amino sequence of kstD8 resem-
bles the b-subunit of PDH complex E1 component, indicating
that KstD7 and KstD8 likely form a heterotetrameric a2b2 com-
plex to catalyze the attachment of a two-carbon side chain
derived from pyruvate (Figure 1E). A similar mechanism was bio-
chemically characterized in yersiniose A biosynthesis (Chen
et al., 1998) and genetically elucidated in avilamycin A pathway
(Treede et al., 2005), which is also consistent with the labeling
experiment performed 40 years ago (Matern and Grisebach,
1972). The other two proteins, a glycosyltransferase (KstD5)
and an activating protein (KstD4), share strong similarity with a
recently characterized family of two-component glycosyltrans-
ferase pairs, including AknK/AknT in aclacinomycin A pathway
(Leimkuhler et al., 2007) and DesVII/DesVIII in pikromycin
biosynthesis (Borisova and Liu, 2010). Together, these enzymes802 Chemistry & Biology 20, 796–805, June 20, 2013 ª2013 Elsevierprovide all the necessary functions that are required for the
biosynthesis of g-branched octose 10 and its attachment to 6
to afford KST (Figures 1E and 1D).
Convergent Assembly of Building Blocks
After generation of the building blocks, the remaining steps are
assembling them together to afford KST. Yet it is still obscure
which enzymes are responsible for the convergent assembly
process. Several genes, encoding proteins with unknown func-
tion according to the bioinformatic analysis, may be involved in
the coupling and tailoring steps, which remain to be further func-
tionally characterized. One of them, kstA12, encodes an enzyme
containing the a/b hydrolase fold domain and shows weak sim-
ilarity with some predicted hydrolases of unknown function.
Inactivation of kstA12 afforded themutant strain TG1710 that still
produces KST and 2with decreased yield but accumulates a pair
of different metabolites with the same mass (m/z = 486) (Fig-
ure 2A, VI). Purification and NMR characterization of this major
compound (Table S6; Figure S10) revealed that the compound
is 5, and the other compound is consistent with 5a (Figure 2B),
which is an isomer of 5 likely produced similarly to the conversion
of KST to 2 (Igarashi et al., 2002). It is likely that KstA12 work as
the carboxylesterase involved in converting 5 to 6, which could
serve as receptor of deoxysugar donor 10 to yield the final
product KST (Figure 1D).
DISCUSSION
In the past 20 years, the biosynthetic platforms of type II PKS
have beenwell studied and successfully applied to produce ‘‘un-
natural’’ natural products by combinatorial biosynthesis (Olano
et al., 2010; Kharel and Rohr, 2012) and even enzymatic total
synthesis (Cheng et al., 2007; Pahari et al., 2012). Although
KST belongs to this family, the structural elements distinguish
its biosynthetic machinery from the common type II PKSs.
Remarkably, KST represents one of the most complex hybrid
natural products and is synthesized by building blocks from
five different sources, including malonyl-CoA, nicotinic acid,
hexose, pyruvate, and pentose monomers. Accordingly, the
biosynthetic machinery of KST is a hybrid system including
type II PKS, NRPS, nicotinic acid metabolic enzymes, deoxysu-
gar biosynthetic enzymes with PDH, and the tryptophan biosyn-
thesis-like enzymes.
A striking feature in KST biosynthesis is the unexpected
precursors and molecular logic used in the formation of the pyr-
rolopyrrole. Because the electron-rich pyrrole ring in natural
products is a useful heterocycle for chemical modification and
biological recognition, the elucidation of nature’s logic and
enzymatic machinery for biological formation of pyrroles has
attracted a lot of interest (Walsh et al., 2006). Currently, amino
acids (such as glycine, proline, serine, threonine, and trypto-
phan), dicarboxylic acids (malonate, oxaloacetate, and succi-
nate), or N-(50-phosphoribosyl)-anthranilate have been charac-
terized as the precursors of pyrrole groups (Walsh et al., 2006;
Siebenberg et al., 2011). Very recently, fructose-6-phosphate
was proposed as the origin of the 4-acetamidopyrrole-2-carbox-
ylate in congocidine biosynthesis (Lautru et al., 2012). KST has
been known for over 40 years, however, the unusual framework
of its pyrrolopyrrole moiety made elucidation of the putativeLtd All rights reserved
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tinic acid as the substrate of KstB1 was totally unexpected, as
nicotinic acid rarely acts as a precursor for natural product
biosynthesis. Few exceptions include a fungal PKS that uses nic-
otinyl-CoA as a starter unit to biosynthesize meroterpenoid (Itoh
et al., 2010). These enzymes similar to the tryptophan biosyn-
thetic pathway were also reasonably assigned to be involved in
the pyrrolopyrrole formation, and the ribofuranose feeding
experiment strongly supports this proposal. The feeding experi-
ment also suggests that a possible aminopyrrole intermediate
may be involved in the construction of pyrrolopyrrole moiety.
This biosynthetic process of pyrrolopyrrole is scarce in the sec-
ondary metabolism, which provides an opportunity for decipher-
ing of the enzymatic logic for construction of this moiety.
Another notable feature of the KST pathway is the hybrid type
II PKS/NRPS system, which is uncommon for bacterial aromatic
polyketide biosynthesis. Three examples containing the hybrid
type II PKS/NRPS have been reported, including enterocin (Izu-
mikawa et al., 2006), lactonamycin (Zhang et al., 2008), and azir-
idine (Ogasawara and Liu, 2009). A common feature of these
three systems is that the discrete A proteins activate the nonace-
tate substrates originating from amino acid or amino acid
metabolite to form its AMP derivatives, which are then loaded
onto the PCP or ACP as a starter unit for type II PKS. However,
the biosynthesis of KST is totally distinct from these types. Both
bioinformatic analysis of CLF (KstA2) and feeding experiments
are consistent with the fact that anthracycline polyketide is syn-
thesized via a polyketide chain of C-20 and an acetate starter
unit. More importantly, characterization of the quinocycline inter-
mediate 3 produced by the mutant TG1708 (DkstB1) strongly
supports that the biosynthesis of the quinocycline building block
catalyzed by type II PKS is independent of the production of the
PCP-tethered building block catalyzed by NRPS using nicotinic
acid as a precursor. Taken together, KstB1/KstB2 is an excep-
tion to the known A/PCP pairs hybrid with type II PKS, which
does not directly engage in the priming step to provide a PKS
starter unit, but is responsible for production of a PCP-tethered
building block parallel to PKS. The enzymatic elucidation of
this system will eventually enrich the current knowledge about
type II PKS.
SIGNIFICANCE
KST belongs to aromatic polyketide natural products
containing a pyrrolopyrrole moiety spirally jointed to a five-
membered ring of an anthraquinone framework glycosy-
lated with a g-branched octose. We have characterized
KST gene cluster and provided the molecular basis for
further exploring the biosynthetic puzzles beyond type II
PKS. Our in vivo and in vitro experiments allow an initial pro-
posal for the biosynthetic pathway of the 2,4,5,6-tetrahydro-
pyrrolo[2,3-b]pyrrole. These findings not only provided an
exceptional example of the hybrid type II PKS/NRPS con-
taining the g-branched octose pathway, but also revealed
a different, hitherto unknown biosynthetic pathway of pyrro-
lopyrrole that use nicotinic acid and ribose as precursors.
Our study also provides a glimpse into how nature
constructs this bicyclic amidine using a tryptophan biosyn-
thesis-like pathway. In addition, the unprecedented charac-Chemistry & Biology 20,teristics also highlight a convergent biosynthetic strategy to
form a spirocyclic skeleton by connecting two building
blocks, rather than the known oxidative C–C bond cleavage.
EXPERIMENTAL PROCEDURES
General
A KST producer, Micromonospora sp. TP-A0468, was cultured as described
(Furumai et al., 2002); other bacterial strains and plasmids used in this study
are summarized in Table S1. PCR amplification was carried out using either
Taq DNA polymerase or PfuUltra DNA polymerase with genomic DNA or fos-
mid as a template and degenerate or specific primers listed in Table S2. The
ORFs were deduced from the sequence by performing FramePlot 4.0beta
program (http://nocardia.nih.go.jp/fp4) and BLAST methods. Amino acid
sequence alignments were performed by the CLUSTALW method from
BIOLOGYWORKBENCH 3.2 software (http://workbench.sdsc.edu). Identifica-
tion of functional domains of PKSs was carried out by using a program pro-
vided at the web site (http://www.nii.res.in/searchall.html). Prediction of amino
acid specificity of the NRPS domain (KstB1) was performed by alignment of
several NRPS A domain including GrsA whose amino acid specificity was
absolutely elucidated via crystal structure determination. This prediction was
performed by using a program at the web site (http://ab.inf.uni-tuebingen.
de/software/NRPSpredictor/welcome.html).
Genomic Library Construction and Screening
A genomic library of Micromonospora sp. TP-A0468 was constructed using
pCC1FOS vector according to the manufacturer’s protocol. The KS gene
probes for library screening were obtained by PCR amplification with primers
KS-For and KS-Rev (Table S2) confirmed by sequencing. The genomic library
(6.03 103 clones) was screened by colony hybridization and the resultant pos-
itive clones were further confirmed by PCR amplification with primers KS-For
and KS-Rev and Southern blotting. To extend the cloned DNA region on the
chromosome, the library was further screened by colony hybridization with
another probe (a PCR fragment with F-walk-For and F-walk-Rev as primers)
from pTG1701 to obtain pTG1702 (Figure 1A; all the PCR primers are summa-
rized in Table S2).
Construction of Gene Disruption and Replacement Mutants
To inactivate the aromatase gene kstA6 of Micromonospora sp. TP-A0468, a
0.85-kb fragment (KstA6-For and KstA6-Rev as PCR primers, Table S2) was
cloned into pOJ260 to yield pTG1703, this plasmid was introduced intoMicro-
monospora sp. TP-A0468 and colonies with apramycin resistance were
identified as single cross-over mutants. Other gene disruption mutants were
constructed following the similar method using different PCR primers (Table
S2). To construct the kstB1 or kstB7 gene replacement mutant, PCR amplifica-
tion using primers B1-For/B1-Rev and B7-For/B7-Rev gained gene disruption
cassettes comprising apramycin resistance gene aac(3)IV, oriT (RK2), and
39-bp homology region of kstB1 and kstB7, respectively. Library fosmid
pTG1701 or pTG1702 and the cassettes were transformed into host E. coli
BW25114 (that was apramycin-resistant and derived from BW25113) sequen-
tially to generate gene-replaced fosmid. The derivate fosmid was introduced
into Micromonospora sp. TP-A0468 by conjugation, then screened and
selected apramycin-resistant, chloramphenicol-sensitive colonies TG1708
and TG1704 as double crossover mutants, whose genotype were tested by
PCR (B1-E-For/B1-E-Rev and B7-E-For/B7-E-Rev as primers, Table S2).
kstC3 gene replacement mutant was constructed in the same way as mutants
TG1708 and TG1704, using primers C3-for /C3-rev to amplify gene disruption
cassette and resulting in double crossover mutant TG1709 (Table S1). The
genotype of DkstC3 mutant was verified by PCR (C3-E-F/C3-E-R as primers,
Table S2).
Production and Analysis of KST
Micromonospora sp. TP-A0468wild-type and recombinant strains were grown
with the seed culture (soluble starch 1%, glucose 0.5%, NZ-case plus 0.3%,
yeast extract 0.2%, tryptone 0.5%, KH2PO4 0.1%, MgSO4 0.05%, CaCO3
0.3%, pH 7.0, and with 50 mg/ml apramycin for recombinant strains) at 30C
for 4–5 days. For fermentation, 3 ml of seed culture suspension was796–805, June 20, 2013 ª2013 Elsevier Ltd All rights reserved 803
Chemistry & Biology
Kosinostatin Biosynthesistransferred into a 500 ml flask containing 100 ml of the fermentation broth
(lactose 4%, cotton seed meal 2%) and incubated at 30C for 2 days, followed
by incubation for another 2 days after adding 4 g sterilized HP20. For KST
isolation, the sediment after certification was extracted twice with acetone,
and the extract was evaporated to remove acetone, extracted twice with ethyl
acetate, washed with saturated NaCl, dried over MgSO4, evaporated, and
finally dissolved with 500 ml methanol.
HPLC analysis was carried out on a Diamonsil C18 column (5 m, 4.6 3
250 mm). The column was equilibrated with 50% solvent A (H2O, 0.1% formic
acid) and B (CH3CN, 0.1% formic acid) and developed with the following
program: 0–24 min, a linear gradient from 76% A/24% B to 40% A/60% B,
24–29 min, a linear gradient from 40% A/60% B to 20% A/80% B, and 29–
30min, a linear gradient from 20%A/80%B to 76%A/24%B. This was carried
out at a flow rate of 1 ml/min and UV detection at 423 nm using an Agilent 1100
HPLC system. The identity of compound was confirmed by LC-MS analysis
performed on LCMS-2010 A (SHIMADZU, JP) under the same condition.
KST showed (M + H)+ ion at m/z of 617.2 consistent with the molecular formula
C33H32N2O10.
Precursor Feeding and Isolation
The fermentation was carried out as mentioned above (Furumai et al., 2002),
equal portions of 13C-labeled precursor (a total of 0.5 g) was added to a growth
culture (1 l) by pulse feeding after 48, 56, 64, 72, and 80 hr of incubation. The
crude extract was applied to silica gel column (100–200 mesh), using
petroleum ether:ethyl acetate (80:20, 60:40, and 40:60, v/v) and methanol:
chloroform (5:95, 10:90, and 20:80, v/v) as the mobile phase. The eluent
when washed with methanol:chloroform (5:95, and 10:90, v/v) was collected
and repeatedly subjected to silica gel column using methanol:dichlorome-
thane: acetic acid (6:94:0.25) as the mobile phase. The eluent was detected
with TLC, collected, and evaporated to give 2.
Production, Isolation, and Elucidation of Compounds
Compound 3 was produced by Micromonospora sp. TG1708 using the same
culture procedures as described for wild-type. For preparation of 3, the HP-20
resin was collected from the fermentation broth, and then flushed with
acetone. The aqueous acetone solution was evaporated to give a residue.
The residue was partitioned between ethyl acetate and H2O. The ethyl acetate
solution was concentrated under reduced pressure to give a brown residue,
which was subjected to gradient silica gel column chromatography eluting
with a step gradient (0%–15% MeOH in CH2Cl2) to yield the pure compound
3 (5 mg/l). HRMS (ESI): m/z = 397.0929 ([M  H]), m/z (calculated [calcd.]) =
397.0925 ([M  H]) consistent with the molecular formula C21H18O8; UV lmax
nm (in 0.01 N HCOOH-CH3CN = 1:3): 216, 257, 290, 312, 432 (Figure S10);
1H
NMR and 13CNMR (see Table S5 and Figure S7). Additionally, the stereochem-
istry of compound 3 is conducted by comparing with auramycinone and
nogalamycinone (Torkkell et al., 2000). Compound 5 was produced byMicro-
monospora sp. TG1710 using the same culture and purification procedures as
described for compound 3. Crude ethyl acetate extracts was eluted with a step
gradient (0%–30% MeOH in CH2Cl2) to yield the pure compound 5 (8 mg/l).
HRMS (ESI): m/z = 487.1500 ([M + H]+), m/z (calcd.) = 487.1519 ([M + H]+)
consistent with the molecular formula C27H22N2O7; UV lmax nm (in 0.01 N
HCOOH-CH3CN = 1:1.3): 229, 257, 290, 312, 430 (Figure S11);
1H NMR
and 13C NMR (see Table S6 and Figure S10).
NRPS Gene Cloning, Expression, and Protein Purification
The genes encoding KstB1 and KstB2 were amplified by PCR from fosmid
pTG1701 with primers B1-E-For/B1-E-Rev and B2-E-For/B2-E-Rev, respec-
tively (Table S2). PCR products were purified, cloned, and confirmed by
sequencing, then NdeI/HindIII fragments for kstB1 and kstB2 were cloned
into the same sites of pET-28a to make the expression plasmid pTG1713
(for kstB1) and pTG1714 (for kstB2). The resulting plasmids were transformed
into E. coli BL21 (DE3) and E. coli Rosetta (DE3), respectively, for protein
expression. Cultures (0.5 l) in LBmedium supplemented with 50 mg/ml of kana-
mycin were grown to anOD600 of 0.4–0.6 at 37
Cand then 16C for 30min, and
protein expression was induced by the addition of 50 mM IPTG. Cultured for
another 24 hr and purified the His-tagged fusion protein with Ni-NTA affinity
resin according to manufacturer’s manual (QIAGEN, Valencia, CA). The resul-
tant proteins were dialyzed against 50 mM Tris-HCl (pH 7.5), 50 mMNaCl, and804 Chemistry & Biology 20, 796–805, June 20, 2013 ª2013 Elsevier10% glycerol, and stored at 80C. According to subsequent analysis (see
Figures 4B and S8), KstB2 was purified as a mixture of apo- and holo-protein,
in which holo-KstB2 is predominate.
Biochemical Assays of NRPS
The PCP aminoacylation reaction (50 ml) contained 75 mM Tris-HCl (pH 7.5),
10 mM MgCl2, 3 mM ATP, 16 mM KstB1, 90 mM KstB2, and 1 mM substrate.
After incubation for a span of 5 min to 30 min at 30C, the reaction was
quenched by adding 20 ml of 10% formic acid and analyzed by HPLC. Control
reactions were performed in the absence of substrate or ATP or KstB1. HPLC
analysis was carried out on a GraceVydac protein & peptide C18 column (W.R.
Grace, CT). The column was equilibrated with 80% solvent A (H2O, 0.1% tri-
fluoroacetic acid) and 20% solvent B (CH3CN, 0.1% trifluoroacetic acid) and
developed with the following program: 0 min, 80% A/20% B, 4 min, 65%
A/35% B, 24 min, 35% A/65% B, 26 min, 5% A/95% B, 28 min, 5% A/95%
B, and 30–35 min, constant 80% A/20% B. It was carried out at a flow rate
of 1 ml/min with UV detection at 220 nm, using an Agilent 1200 HPLC system.
LC/MS analysis was carried out by the Agilent 6530 Accurate-Mass Quadro-
pole Time-of-Flight.
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